Anti-TIGIT Recombinant Antibody Products

Loading...

Anti-TIGIT Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.

Creative Biolabs is proud to offer a superior range of anti-TIGIT recombinant antibody products, meticulously designed to empower global researchers in their cutting-edge immunotherapy endeavors. Our commitment to excellence ensures that these antibodies provide unparalleled specificity and activity, accelerating the development of next-generation cancer treatments and beyond.

TIGIT: A Promising Target for Cancer Immunotherapy

TIGIT (T cell immunoreceptor with Ig and ITIM domains) is a crucial immune checkpoint receptor expressed on various immune cells, including T cells and NK cells. Its interaction with ligands like CD155 and CD112 suppresses anti-tumor immune responses, contributing to immune evasion in the tumor microenvironment. Extensive research highlights TIGIT's significant role in numerous cancers, making it a highly promising target for novel immunotherapeutic strategies aimed at restoring effective anti-tumor immunity and improving patient outcomes.

Alternative Names

T cell immunoreceptor with Ig and ITIM domains; VSIG9; VSTM3; WUCAM; T-cell immunoreceptor with Ig and ITIM domains.

Background

This gene encodes a member of the PVR (poliovirus receptor) family of immunoglobin proteins. The product of this gene is expressed on several classes of T cells including follicular B helper T cells (TFH). The protein has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses. [provided by RefSeq, Sep 2009]

Anti-TIGIT rAb Products

Our anti-TIGIT recombinant antibody products stand at the forefront of immunotherapy research, offering exceptional purity, high affinity, and superior batch-to-batch consistency. These antibodies, produced utilizing modern recombinant technology, provide consistent and repeatable results for your crucial tests. Their optimized design provides enhanced binding specificity, minimizing off-target effects and maximizing experimental precision across diverse applications.

Table 1. Featured anti-TIGIT recombinant antibody products at Creative Biolabs.

Creative Quality Control

Creative Biolabs' anti-TIGIT recombinant antibodies undergo rigorous, multi-faceted quality control measures, including comprehensive binding assays, functional validation, and purity analysis. This careful method ensures that each product satisfies the highest industry standards for performance and dependability, giving researchers confidence in their experimental results.

Customer Reviews

Excellent

Ro***n
Human Anti-TIGIT Recombinant Antibody (HPAB-0669YY) (HPAB-0669YY)

The anti-TIGIT recombinant antibody from Creative Biolabs significantly streamlined our in vitro studies. Its consistent performance and high specificity saved us considerable time and resources, allowing us to generate reliable data much faster. We were particularly impressed with its low background, which made our analysis straightforward and accurate.

13/Oct/2023

Excellent

Da***i
Human Anti-TIGIT Recombinant Antibody (HPAB-0775YY) (HPAB-0775YY)

For our flow cytometry application, Creative Biolabs' anti-TIGIT recombinant antibody proved to be exceptionally versatile. The clear and strong signals we observed were crucial for our cellular analysis, providing high-resolution data. This product has truly elevated the quality and depth of our research findings.

20/May/2024

Excellent

Ve***t
Mouse Anti-TIGIT Recombinant Antibody (HPAB-2959LY) (HPAB-2959LY)

We've incorporated Creative Biolabs' anti-TIGIT antibody into our preclinical models, and the results have been outstanding. The antibody displayed great in vivo effectiveness, which matched exactly with our study aims. Its robust activity and reliable batch consistency make it an indispensable tool for our ongoing therapeutic development.

15/Nov/2024

rAb Production

The production of our anti-TIGIT recombinant antibody products is executed within state-of-the-art mammalian expression systems. This methodology ensures optimal post-translational modifications and preserves intrinsic biological activity. This advanced production platform facilitates large-scale manufacturing while upholding rigorous quality standards, thereby providing researchers with a consistent and ample supply of high-performance antibodies essential for their projects.

Featured Anti-TIGIT Recombinant Antibody Production Platforms
Fig.6 Milligram-scale anti-TIGIT recombinant antibody production.

Fig.7 Gram-scale anti-TIGIT recombinant antibody production.

rAb Modalities

We offer anti-TIGIT recombinant antibodies in various modalities, catering to diverse research and therapeutic development needs.

Fig.8 Full-length anti-TIGIT recombinant antibody production and modalities.

TIGIT-Targeted Drug Information

Table 2. Public drug targeting TIGIT.

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

Creative Biolabs is dedicated to accelerating your research with our premium anti-TIGIT recombinant antibody products. We invite you to explore our comprehensive portfolio and discover how our expertise can support your scientific breakthroughs. For detailed product information, technical support, or to discuss your specific project requirements, please do not hesitate to reach out to us.